Financial Gravity Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18
| Closed | -$522 | – | 2262 |
|
|
2024
Q1 | $522 | Buy |
+18
| New | +$522 | ﹤0.01% | 1364 |
|
|
2023
Q3 | – | Sell |
-28
| Closed | -$470 | – | 1645 |
|
|
2023
Q2 | $470 | Buy |
+28
| New | +$470 | ﹤0.01% | 1012 |
|
|
2023
Q1 | – | Sell |
-11
| Closed | -$197 | – | 1533 |
|
|
2022
Q4 | $197 | Buy |
+11
| New | +$197 | ﹤0.01% | 950 |
|
|
2020
Q1 | – | Sell |
-55
| Closed | -$7K | – | 1318 |
|
|
2019
Q4 | $7K | Hold |
55
| – | – | ﹤0.01% | 1237 |
|
|
2019
Q3 | $1K | Hold |
55
| – | – | ﹤0.01% | 1092 |
|
|
2019
Q2 | $1K | Hold |
55
| – | – | ﹤0.01% | 1116 |
|
|
2019
Q1 | $1K | Buy |
+55
| New | +$1K | ﹤0.01% | 1166 |
|
|
2018
Q3 | $0 | Hold |
55
| – | – | ﹤0.01% | 1580 |
|
|
2018
Q2 | $1K | Buy |
55
+53
| +2,650% | +$964 | ﹤0.01% | 1242 |
|
|
2018
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1496 |
|